日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease

单个卤素原子取代对靶向SARS-CoV-2主蛋白酶抑制剂抗病毒活性的影响

Bulut, Haydar; Higashi-Kuwata, Nobuyo; Ogata-Aoki, Hiromi; Hayashi, Hironori; Takamune, Nobutoki; Kishimoto, Naoki; Das, Debananda; Li, Mi; Wlodawer, Alexander; Misumi, Shogo; Tamamura, Hirokazu; Mitsuya, Hiroaki

Macrophages with different origins proliferate ex vivo and do not lose their core intrinsic features

不同来源的巨噬细胞在体外增殖后不会丧失其核心固有特征。

Sara A Habash ,Naofumi Takahashi ,Youssef M Eltalkhawy ,Randa A Abdelnaser ,Hiromi Ogata-Aoki ,Seiji Okada ,Hitoshi Takizawa ,Shingo Usuki ,Kan Etoh ,Shinjiro Hino ,Saori Morino-Koga ,Minetaro Ogawa ,Shinya Suzu

An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier

口服 P1'-5-氟化 Mpro 抑制剂无需加强剂即可阻断 SARS-CoV-2 复制,且具有较高的遗传屏障

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi, Kohei Tsuji, Hiromi Ogata-Aoki, Maki Kiso, Nobutoki Takamune, Naoki Kishimoto, Shin-Ichiro Hattori, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Yukiko Shimizu, Debananda Das, Junji Saruwatari, Kazuya Hasegawa, Kazutaka Murayama, Yoshikazu S

Establishment of Biobank and Patient-Derived Xenograft of Soft Tissue and Bone Tumors

建立软组织和骨肿瘤生物样本库及患者来源异种移植模型

Okada, Seiji; Boonnate, Piyanard; Panaampon, Jutatip; Saisuwan, Krittamate; Ogata-Aoki, Hiromi; Abe, Makoto; Hirabayashi, Kaoru; Nakagawa, Rumi; Kikuta, Kazutaka

Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

鉴定含有P1' 4-氟苯并噻唑基团的SARS-CoV-2 Mpro抑制剂,该抑制剂对SARS-CoV-2具有高度活性

Nobuyo Higashi-Kuwata,Kohei Tsuji,Hironori Hayashi,Haydar Bulut,Maki Kiso,Masaki Imai,Hiromi Ogata-Aoki,Takahiro Ishii,Takuya Kobayakawa,Kenta Nakano,Nobutoki Takamune,Naoki Kishimoto,Shin-Ichiro Hattori,Debananda Das,Yukari Uemura,Yosuke Shimizu,Manabu Aoki,Kazuya Hasegawa,Satoshi Suzuki,Akie Nishiyama,Junji Saruwatari,Yukiko Shimizu,Yoshikazu Sukenaga,Yuki Takamatsu,Kiyoto Tsuchiya,Kenji Maeda,Kazuhisa Yoshimura,Shun Iida,Seiya Ozono,Tadaki Suzuki,Tadashi Okamura,Shogo Misumi,Yoshihiro Kawaoka,Hirokazu Tamamura,Hiroaki Mitsuya

Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV

鉴定出一种新型长效4'-修饰核苷类逆转录酶抑制剂,用于对抗乙型肝炎病毒

Higashi-Kuwata, Nobuyo; Hayashi, Sanae; Kumamoto, Hiroki; Ogata-Aoki, Hiromi; Das, Debananda; Venzon, David; Hattori, Shin-Ichiro; Bulut, Haydar; Hashimoto, Mai; Otagiri, Masaki; Takamune, Nobutoki; Kishimoto, Naoki; Davis, David A; Misumi, Shogo; Kakuni, Masakazu; Tanaka, Yasuhito; Mitsuya, Hiroaki

Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1(JR-FL) in the setting of post-exposure prophylaxis in NOD/SCID/Jak3(-/-) mice transplanted with human PBMCs

在接受人外周血单核细胞移植的NOD/SCID/Jak3(-/-)小鼠中,拉替拉韦可阻断暴露后预防中红色荧光蛋白(mCherry)标记的HIV-1(JR-FL)的感染性。

Ogata-Aoki, Hiromi; Higashi-Kuwata, Nobuyo; Hattori, Shin-Ichiro; Hayashi, Hironori; Danish, Matthew; Aoki, Manabu; Shiotsu, Chiemi; Hashiguchi, Yumi; Hamada, Akinobu; Kobayashi, Hisataka; Ihn, Hironobu; Okada, Seiji; Mitsuya, Hiroaki

Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3(-/-) mice

在移植了人外周血单核细胞的NOD/SCID/Jak3(-/-)小鼠中,可追踪的携带mCherry荧光蛋白的HIV-1感染的早期动力学

Higashi-Kuwata, Nobuyo; Ogata-Aoki, Hiromi; Hattori, Shin-Ichiro; Hayashi, Hironori; Danish, Matthew; Aoki, Manabu; Shiotsu, Chiemi; Kawamura, Tatsuyoshi; Ihn, Hironobu; Kobayashi, Hisataka; Okada, Seiji; Mitsuya, Hiroaki

Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions

CC 趋化因子受体 5 (CCR5) 抑制剂对 CCR5 和 CC-趋化因子-CCR5 相互作用动力学的影响

Hirotomo Nakata, Michael Kruhlak, Wakako Kamata, Hiromi Ogata-Aoki, Jianfeng Li, Kenji Maeda, Arun K Ghosh, Hiroaki Mitsuya

Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition

CCR5 的第二个胞外环和跨膜残基参与抑制剂结合和 HIV-1 融合:对变构抑制机制的见解

Kenji Maeda, Debananda Das, Philip D Yin, Kiyoto Tsuchiya, Hiromi Ogata-Aoki, Hirotomo Nakata, Rachael B Norman, Lauren A Hackney, Yoshikazu Takaoka, Hiroaki Mitsuya